|
|
00.10 Implantation of chemotherapeutic agent
Brain wafer chemotherapy
Interstitial/ intracavitary
Excludes: injection or infusion of cancer chemotherapeutic substance (99.25) |
00.11 Infusion of drotrecogin alfa (activated)
Infusion of recombinant protein |
00.12 Administration of inhaled nitric oxide
Nitric oxide therapy |
00.13 Injection or infusion of nesiritide
Human B-type natriuretic peptide (hBNP) |
00.14 Injection or infusion of oxazolidinone class of antibiotics
Linezolid injection |
00.15 High-dose infusion interleukin-2 [IL-2]
Infusion (IV bolus, CIV) interleukin
Injection of aldesleukin
Excludes: low-dose infusion interleukin-2 (99.28) |
00.16 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance
Ex-vivo treatment of vessel
Hyperbaric pressurized graft [conduit] |
00.17 Infusion of vasopressor agent |
00.18 Infusion of immunosuppressive antibody therapy
Includes: during induction phase of solid organ transplantation
monoclonal antibody therapy
polyclonal antibody therapy |
00.19 Disruption of blood brain barrier via infusion [BBBD]
Infusion of substance to disrupt blood brain barrier
Code also chemotherapy (99.25)
Excludes: other perfusion (39.97) |